Showing results (221-230 of 370) with videos related to

Sort By:
Pageof 37
Journal of Medical Virology|May 29, 2009
Two decades of hepatitis B infections among drug users in Amsterdam: are they still a high-risk group?Robin van Houdt, Charlotte H S B van den Berg, Ineke G Stolte, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2024
Hepatitis C Treatment and Behavioral Risk Among Men Who Have Sex With Men With HIV: Comparing Interferon and Direct-Acting Antiviral ErasKris Hage, Anders Boyd, Daniela K van Santen, et al.
Sexually Transmitted Diseases|January 10, 2022
Factors Associated With the Intention to Use HIV Preexposure Prophylaxis for Young and Older Men Who Have Sex With MenSebastiaan H Hulstein, Hanne M L Zimmermann, Feline de la Court, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2011
Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and AustraliaInma Jarrin, Nikos Pantazis, M John Gill, et al.
AIDS Research and Human Retroviruses|April 10, 2010
Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infectionRadjin Steingrover, Evian Fernandez Garcia, Irene G M van Valkengoed, et al.
Sexually Transmitted Infections|May 18, 2022
Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP StudyVita W Jongen, Hanne M L Zimmermann, Marit Goedhart, et al.
AIDS (London, England)|June 29, 2017
MSM starting preexposure prophylaxis are at risk of hepatitis C virus infectionElske Hoornenborg, Roel C A Achterbergh, Maarten F Schim van der Loeff, et al.
Kidney International Reports|July 9, 2025
Renal Outcomes Over the Course of 5 Years of Oral HIV Preexposure Prophylaxis Using Tenofovir Disoproxil/EmtricitabineDita C Bolluyt, Mark A M van den Elshout, Eline S Wijstma, et al.
European Journal of Public Health|July 8, 2026
SARS-CoV-2 testing uptake and its determinants in six ethnic groups living in Amsterdam, the Netherlands: a registry-based study within the HELIUS cohortSophie L Campman, Anders Boyd, Nina van Wilgen, et al.
BMC Infectious Diseases|December 5, 2018
Differences in Chlamydia trachomatis seroprevalence between ethnic groups cannot be fully explained by socioeconomic status, sexual healthcare seeking behavior or sexual risk behavior: a cross-sectional analysis in the HEalthy LIfe in an Urban Setting (HELIUS) studySebastiaan H Hulstein, Amy Matser, Catharina J Alberts, et al.
Pageof 37